Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...